Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas

Bone Marrow Transplant. 2019 Feb;54(2):330-333. doi: 10.1038/s41409-018-0289-z. Epub 2018 Aug 6.

¹ Department of Hematology, Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² Department of Hematology, Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. chosg@catholic.ac.kr.
³ Institute for Translational Research and Molecular Imaging, The Catholic University of Korea College of Medicine, Seoul, Korea. chosg@catholic.ac.kr.

No abstract available

Publication types